Glioblastoma multiforme (GBM) is the most aggressive form of brain tumours. GBM treatment
is challenging because tumours are highly invasive and it is difficult to achieve effective …

The treatment for glioblastoma multiforme (GBM) has not changed for more than 20 years
while the prognosis for the patients is still poor and most of them survive less than 1 year …

Malignant gliomas are a type of primary brain tumour that originates in glial cells. Among
them, glioblastoma multiforme (GBM) is the most common and the most aggressive brain …

The limitations and negative effects of current therapeutic techniques for brain tumors
necessitate the selection of alternative therapeutic options. Therapeutic hydrogel systems …

The management of brain tumors presents numerous challenges, despite the employment of
multimodal therapies including surgical intervention, radiotherapy, chemotherapy, and …

Among central nervous system tumors, Glioblastoma (GBM) is the most common, aggressive
and neurological destructive primary brain tumor in adults. Standard care therapy for GBM …

Chemotherapy is commonly associated with limited effectiveness and unwanted side effects
in normal cells and tissues, due to the lack of specificity of therapeutic agents to cancer cells …

Glioblastoma multiforme (GBM) is a high recidivism and mortality characterized subtype of
gliomas. According to the WHO, it belongs to the Grade IV brain cancers. It is highly invasive …

Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults.
Despite aggressive surgical and medical treatments, the prognosis for patients with GBM …

Glioblastoma (GBM) is the most aggressive malignant brain tumor and is associated with a
very poor prognosis. The standard treatment for newly diagnosed patients involves total …